SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
1.835
-0.033 (-1.77%)
Jun 5, 2025, 4:00 PM - Market closed

SAB Biotherapeutics Market Cap

SAB Biotherapeutics has a market cap or net worth of $17.05 million as of June 5, 2025. Its market cap has decreased by -46.45% in one year.

Market Cap
17.05M
Enterprise Value
10.98M
1-Year Change
-46.45%
Ranking
Category
Stock Price
$1.83

Market Cap Chart

Since February 9, 2021, SAB Biotherapeutics's market cap has decreased from $130.75M to $17.05M, a decrease of -86.96%. That is a compound annual growth rate of -37.59%.

History

DateMarket Cap% Change
Jun 5, 202517.05M-51.31%
Dec 31, 202435.02M-44.79%
Dec 29, 202363.43M113.36%
Dec 30, 202229.73M-91.24%
Dec 31, 2021339.54M159.68%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 670.72B
Johnson & Johnson 373.90B
AbbVie 330.30B
Novo Nordisk 323.14B
UnitedHealth Group 276.42B
Abbott Laboratories 232.39B
Novartis AG 228.01B
AstraZeneca 222.18B
Market Cap Rankings